Swedish Orphan Biovitrum AB, commonly known as Sobi, is a specialty biopharmaceutical company based in Sweden. It develops and supplies medicines for people with rare diseases, with a particular focus on haemophilia and other bleeding disorders, and it also provides treatments in immunology and inflammation. Its customers are mainly healthcare providers, hospitals and specialist clinics that care for patients with these uncommon conditions, and its products are used across European and other international markets.
On this site Swedish Orphan Biovitrum AB appears as a stock on the London Stock Exchange (UK), code 0MTD, with prices in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Strong price profile
Ranks #187 of 3788 on the London Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendStrong
75/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average9.1%
From 52-week high-4.1%
MomentumStrong
72/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return0.5%
6-month return16.3%
12-month, skipping last month35.4%
Stability (higher is calmer)Strong
79/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)26.1%
Worst drawdown, 1 year (smaller is calmer)-15.6%
LiquidityStrong
84/100
Trades actively.
See the numbers →
Avg daily value traded40.00M SEK
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 315.80 – 486.40Daily closes, split-adjusted
Signals
50-day average446.76
200-day average424.35
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)9.97
Technical summary
Daily
Strongly bullish
12 bullish · 1 neutral · 3 bearish
Weekly
Strongly bullish
11 bullish · 1 neutral · 0 bearish
Monthly
Strongly bullish
7 bullish · 0 neutral · 1 bearish
Moving averages (daily)
SMA 10
447.3
Bullish
EMA 10
449.2
Bullish
SMA 20
438.8
Bullish
EMA 20
444.5
Bullish
SMA 50
446.8
Bullish
EMA 50
444.9
Bullish
SMA 100
451.4
Bullish
EMA 100
441.5
Bullish
SMA 200
424.4
Bullish
EMA 200
420.3
Bullish
Oscillators (daily)
RSI (14)
63.58
Neutral
MACD (12, 26)
3.69
Bullish
Momentum (12)
8.28
Bullish
Stochastic %K (14)
100.0
Bearish
Williams %R (14)
0.00
Bearish
CCI (20)
153.8
Bearish
Pivot points (classic, last session)
S3
436.3
S2
441.6
S1
452.4
Pivot
457.7
R1
468.5
R2
473.8
R3
484.6
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in SEK. Educational only, not financial advice.
